Head and Neck Cancer Clinical Trial
— PETALOfficial title:
Therapeutic Education Program Aimed at Improving the Quality of Life of Laryngectomised Patients and Their Close Relatives
The therapeutic education of patients and their close relations is, as yet, poorly developed
in France in the field of oncology, in particular for cancers of the upper aerodigestive
tract. In the case of pharyngeal and laryngeal cancer, total laryngectomy associated with
radiotherapy remains a reference treatment for advanced stage cancers. This mutilating
surgical procedure has a major impact on the patient's life, due to its physical and
functional sequelae. Its psychosocial consequences are also important, owing to the
biographical disruption and the identity-related metamorphoses associated with illness and
its treatment, which alter the quality of life not only of patients, but also of their close
relations. Currently, care for laryngectomised patients consists essentially in informing
and educating them on certain technical procedures during hospital admission. New voice
education can be a long process and often involves the intervention of a speech therapist,
who serves as the link between the patient and the hospital care team. These healthcare
modalities often insufficiently account for the social, environmental and personal factors
that interact in health-related problems.
The aim is to design, implement and evaluate a patient therapeutic education (PTE)
programme, for laryngectomised patients and their close relations, aimed at improving their
quality of life.
The research will be conducted over three phases:
The first phase, referred to as the "pilot" phase, will include exploratory, observational
and retrospective analysis aimed at developing knowledge on the consequences of laryngectomy
on the quality of life of patients and their close relations, the strengths and weaknesses
of current practice in patient support and the needs expressed by the players involved
(patients, relations, professional carers). This analysis will be conducted via interviews
with patients and their close relations and focus groups with the healthcare professionals
involved in patient care and support (hospital and independent). This first phase will
enable the pluridisciplinary design of a therapeutic education programme for laryngectomised
patients and their close relations which will be tested in the study's principle
coordinating centre. The method defined thus is in keeping with quality criteria set by the
HAS specifying that the PTE should focus on the patient, be scientifically justified, and be
developed by a pluridisciplinary group reuniting representatives of patients or patient
associations.
The second phase, referred to as the prospective intervention "replication" phase, aims at
evaluating the programme's transferability and quality in three centres. The centres
participating in this second phase already have experience in the development of PTE
programmes and will be involved in the workgroup entrusted with the design of the PETAL
programme during phase 1.
The third phase, referred to as the "randomised" multicentric comparative intervention
phase, should enable us to assess the benefits of the developed PTE programme on the quality
of life of patients and their close relations.
This is a pluridisciplinary study via which we hope to improve the quality of life of
laryngectomised patients and their close relations through the design and the sustainable
deployment of an innovative PTE programme in France and Belgium. This project also aims at
reinforcing town-hospital links to improve help, follow-up and support for patients and
their close relations, as well as dialogue between healthcare professionals.
Status | Active, not recruiting |
Enrollment | 40 |
Est. completion date | July 2018 |
Est. primary completion date | December 2017 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Patient (18-70 years) treated with total laryngectomy for cancer of the larynx, pharynx or cervical esophagus - Patient agreeing to participate in the study (informed consent) - Person designated as close relative by the laryngectoised patient (support person, spouse, parent, caregiver) - Close relative agreeing to participate in the study (informed consent) after the patient himself has authorized the investigator to contact that person to offer to participate in the study - Time since laryngectomy (group 1 : 1 month, group 2: 3 months, group 3: 6 months, group 4 : 12 months) Exclusion Criteria: - Physical , mental, cognitive or psychiatric disabilityof the patient to answer questions and participate in interviews and therapeutic education program - Physical , mental, psychiatric or cognitive disability of the close relative to answer questions and participate in interviews and therapeutic education program |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
France | Caen Cancer Institute | Caen | |
France | Caen University Hospital | Caen | |
France | Lille Cancer Institute | Lille | |
France | Lille University Hospital | Lille |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Caen | CERFEP CARSAT Nord-Picardie, INSERM U1086 Cancers et Préventions, University of Lille Nord de France |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | interview of patient and close relatives | design, implement and evaluate a patient therapeutic education (PTE) programme, for laryngectomised patients and their close relations, aimed at improving their quality of life. | baseline | No |
Secondary | transferability of patient therapeutic education (PTE) | evaluating the programme's transferability in three centres | during 1 year | No |
Secondary | quality of patient therapeutic education (PTE) | evaluating the programme's quality in three centres | during 1 year | No |
Secondary | quality of life (QLQC30) | to assess the benefits of the developed PTE programme on the quality of life of patients and their close relations | baseline and 1 year after PTE | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05808920 -
The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck
|
||
Completed |
NCT02526017 -
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers
|
Phase 1 | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT03997643 -
Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT04700475 -
Effect of Low Level Laser Therapy on Prevention of Radiotherapy Induced Xerostomia in Cancer Patients.
|
N/A | |
Withdrawn |
NCT04058145 -
AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma
|
Phase 2 | |
Completed |
NCT02572869 -
Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps
|
||
Active, not recruiting |
NCT04474470 -
A Study to Evaluate NT219 Alone and in Combination With ERBITUX® (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer
|
Phase 1/Phase 2 | |
Withdrawn |
NCT05073809 -
Photoacoustic Imaging of Head and Neck Tumours
|
||
Active, not recruiting |
NCT04383210 -
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
|
Phase 2 | |
Active, not recruiting |
NCT03651570 -
Randomized Controlled Trial of a E-intervention to Help Patients Newly Diagnosed With Cancer Cope Better: Pilot Study
|
N/A | |
Recruiting |
NCT04930432 -
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06016699 -
Immunological Function After Radiation With Either Proton or Photon Therapy
|
||
Terminated |
NCT03843554 -
Commensal Oral Microbiota in Head and Neck Cancer
|
N/A | |
Recruiting |
NCT05915572 -
Mulligan Technique on Shoulder Dysfunction
|
N/A | |
Completed |
NCT05897983 -
Tens and Rocabado Exercises on TMJ Dysfunction
|
N/A | |
Not yet recruiting |
NCT06289049 -
Heavy Strength Training in Head and Neck Cancer Survivors
|
Phase 2 | |
Withdrawn |
NCT05263648 -
Virtual Reality Software to Reduce Stress in Cancer Patients
|
N/A | |
Withdrawn |
NCT03238638 -
A Study of Epacadostat + Pembrolizumab in Head and Neck Cancer Patients, Who Failed Prior PD-1/PD-L1 Therapy
|
Phase 2 |